Clinical Trial Update: Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating aflibercept for safety and efficacy in naive patients with uncomplicated proliferative diabetic retinopathy (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Naive Patients With Uncomplicated Proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED